N-acetylcysteine in the treatment of craving in substance use disorders: Systematic review and meta-analysis.

Michel Silvio DuailibiQuirino CordeiroElisa BrietzkeMarcelo RibeiroSteve LaRoweMichael BerkAlisson Paulino Trevizol

Published in: The American journal on addictions (2017)

The safety profile of NAC and its favorable tolerability, in addition to being anover-the-counter medication, presents with an interesting potential clinical use for craving in SUDs. (Am J Addict 2017;26:660-666).

Keyphrases

transcription factor
healthcare
open label
randomized controlled trial
emergency department
risk assessment
study protocol
placebo controlled
genome wide analysis